617 related articles for article (PubMed ID: 18043040)
1. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis.
Jones TD; Zhang S; Lopez-Beltran A; Eble JN; Sung MT; MacLennan GT; Montironi R; Tan PH; Zheng S; Baldridge LA; Cheng L
Am J Surg Pathol; 2007 Dec; 31(12):1861-7. PubMed ID: 18043040
[TBL] [Abstract][Full Text] [Related]
2. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
3. [Urothelial carcinoma with an inverted growth pattern: a report of 4 cases].
Dzombeta T; Krajacić-Jagarcec G; Tomas D; Kraus O; Ruzić B; Kruslin B
Acta Med Croatica; 2010 Mar; 64(1):47-50. PubMed ID: 20653125
[TBL] [Abstract][Full Text] [Related]
4. Inverted urothelial papilloma of the urinary bladder with focal papillary pattern: a previously undescribed feature.
Albores-Saavedra J; Chable-Montero F; Hernández-Rodríguez OX; Montante-Montes de Oca D; Angeles-Angeles A
Ann Diagn Pathol; 2009 Jun; 13(3):158-61. PubMed ID: 19433293
[TBL] [Abstract][Full Text] [Related]
5. [Cytokeratins in inverted papillomas of the urinary bladder. (Part 1.)].
Stosiek P; Kasper M; Seidenschnur A; Goertchen R
Pathologe; 1993 Dec; 14(6):330-3. PubMed ID: 7510066
[TBL] [Abstract][Full Text] [Related]
6. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
[TBL] [Abstract][Full Text] [Related]
7. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases.
Lin O; Cardillo M; Dalbagni G; Linkov I; Hutchinson B; Reuter VE
Mod Pathol; 2003 Dec; 16(12):1289-98. PubMed ID: 14681330
[TBL] [Abstract][Full Text] [Related]
8. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
9. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
[TBL] [Abstract][Full Text] [Related]
10. Do different disorders in cell cycle regulation account for different biological behavior of urothelial and sinonasal inverted papillomas?
Gunia S; Fritzsche F; May M; Liebe D; Koch S
Pathobiology; 2008; 75(1):34-41. PubMed ID: 18334838
[TBL] [Abstract][Full Text] [Related]
11. Molecular and immunohistologic analyses cannot reliably solve diagnostic variation of flat intraepithelial lesions of the urinary bladder.
Murata S; Iseki M; Kinjo M; Matsuzaki O; Moriuchi A; Ohtani H; Sakurai T; Satake T; Tsuzuki T
Am J Clin Pathol; 2010 Dec; 134(6):862-72. PubMed ID: 21088148
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
13. Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management.
Hodges KB; Lopez-Beltran A; Maclennan GT; Montironi R; Cheng L
BJU Int; 2011 Feb; 107(4):532-7. PubMed ID: 21091975
[TBL] [Abstract][Full Text] [Related]
14. Possible prognostic significance of p53 and Ki 67 in inverted sinonasal papilloma.
Bura M; Seiwerth S; Vladika I; Perović D; Nagy P; Corić M; Bijelić L; Krajina Z; Mitrecić MZ
Coll Antropol; 2007 Jun; 31(2):545-9. PubMed ID: 17847937
[TBL] [Abstract][Full Text] [Related]
15. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
16. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
17. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
Yin H; Leong AS
Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
[TBL] [Abstract][Full Text] [Related]
18. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.
Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L
Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188
[TBL] [Abstract][Full Text] [Related]
19. Invasive micropapillary urothelial carcinoma of the bladder.
Lopez-Beltran A; Montironi R; Blanca A; Cheng L
Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical study of p53 and Ki-67 in inverted papillomas and nasal polyps arising from nasal or paranasal regions].
Ikegawa K; Matsukuma S
Rinsho Byori; 2005 Jun; 53(6):499-503. PubMed ID: 16026075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
